A Busy Week for Multiple Sclerosis News
It was good news for Novartis and bad news for Merck KGaA this week as regulators handed down their decisions on each company’s multiple sclerosis (MS) drug candidate.
1007
Three Trends That Will Impact Pharma’s Future
The future of the pharmaceutical industry depends on three key trends, says a recent editorial in the Harvard Business Review.